Posted on 8/15/19
Concierge Medicine Company, Paragon Private Health, Recognized for 2nd Consecutive Year by Inc. 5000
Paragon Private Health, with offices in New York, NY and Richmond, VA has been named to the prestigious Inc. 5000 list of the fastest growing private . . .
Posted on 8/15/19
Rectangle Health Named One Of America's 5,000 Fastest-Growing Companies By Inc. Magazine
Inc. magazine revealed today that Rectangle Health is No. 3973 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. . . .
Posted on 8/15/19
For the 2nd Consecutive Year, Competitive Health, Inc. Appears on the Inc. 5000
Inc. magazine today revealed that Competitive Health, Inc. is No. 3072 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private . . .
Posted on 8/15/19
The Lockwood Group Once Again Recognized as an Inc. 5000 Fastest Growing Private Company in America
The Lockwood Group (Lockwood), a medical communications agency, has been recognized by Inc. magazine in their 2019 Inc. 5000 annual ranking of the fastest-growing private companies . . .
Posted on 8/15/19
Concierge Medicine Company, Paragon Private Health, Recognized for 2nd Consecutive Year by Inc. 5000
Paragon Private Health, with offices in New York, NY and Richmond, VA has been named to the prestigious Inc. 5000 list of the fastest growing private . . .
Posted on 8/14/19
Alzheimer's Foundation of America Awards $100,000 Grant to NYU Winthrop Hospital
The Alzheimer's Foundation of America (AFA) today announced a $100,000grant to NYU Winthrop Hospital for a research project aimed at uncovering the underlying causes of Alzheimer's . . .
Posted on 8/13/19
Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic, a biotechnology company focused on developing a new class of oral . . .
Posted on 8/13/19
Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
BEDMINSTER, N.J. , Aug. 13, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced financial results for the . . .
Posted on 8/13/19
AzurRx BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, . . .
Posted on 8/13/19
Pfizer's Dividend Confusion Is Likely To Create Opportunity
SummaryPfizer recently announced the spin-off of Upjohn, which manufactures Pfizer's off-patent drugs. The deal will bring in $12 billion.Pfizer also recently acquired Array for its biotech . . .
Posted on 8/13/19
PharmScript Opens Third Pharmacy in Texas
PharmScript, a leading pharmacy provider to long-term care and post-acute care facilities, today announced the opening of a new pharmacy in Abilene, Texas. The pharmacy leverages . . .
Posted on 8/12/19
Applied Therapeutics Reports Second Quarter 2019 Financial Results
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet . . .
Posted on 8/11/19
Stemline Therapeutics Prices $76,250,000 Public Offering of Common Stock
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology . . .
Posted on 8/9/19
ContraFect Reports Second Quarter 2019 Financial Results and Provides Business Update
YONKERS, N.Y., Aug. 09, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), . . .
Posted on 8/9/19
Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced financial results for the second quarter 2019 and provided a business update.“We . . .
Posted on 8/9/19
TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended June 30, 2019 . . .
Posted on 8/9/19
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, . . .
Posted on 8/9/19
Celgene: Timing The Switch To Bristol-Myers
SummaryBristol-Myers is expected to close on the Celgene merger around year-end.The deal is about 50% cash and stock with an additional tradable CVR requiring investors to . . .
Posted on 8/9/19
Celldex Therapeutics Keeps Up Its Penny-Pinching and Pipeline Progress
Celldex Therapeutics (NASDAQ:CLDX) has two primary goals in 2019. First, the biotech wants to advance its pipeline candidates. Second, it wants to stretch out its cash . . .
Posted on 8/8/19
Bellerophon Provides Business Update
WARREN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update . . .
Posted on 8/8/19
TYME Provides Business Update
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today provided a business . . .
Posted on 8/8/19
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
LONDON and NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the pricing . . .
Posted on 8/8/19
ADMA Biologics Reports Q2 and First Half 2019 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company . . .
Posted on 8/8/19
Henry Schein Medical Expands Its SolutionsHub Portfolio With GreenLight Behavioral Assessments
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., today announced the expansion of its SolutionsHub into the behavioral health space with . . .
Posted on 8/8/19
Eagle Pharmaceuticals Reports Second Quarter 2019 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced its financial results for the three- and six-months ended June 30, 2019. Highlights of, and subsequent . . .

